Home > Income Statement > ORCHID PHARMA

ORCHID PHARMA
Consolidated Net Profit

    Back to Income Statement
ORCHID PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹100 Cr₹92 Cr₹46 Cr₹-1.95 Cr₹-117 Cr

What is the latest Consolidated Net Profit of ORCHID PHARMA ?

The latest Consolidated Net Profit ratio of ORCHID PHARMA is ₹100 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹100 Cr
Mar2024₹92 Cr
Mar2023₹46 Cr
Mar2022₹-1.95 Cr
Mar2021₹-117 Cr

How is Consolidated Net Profit of ORCHID PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹100 Cr
8.13
Mar2024 ₹92 Cr
98.99
Mar2023 ₹46 Cr
Positive
Mar2022 ₹-1.95 Cr
Negative
Mar2021 ₹-117 Cr -

Compare Consolidated Net Profit of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹5,008.7 Cr -5.6% -0.3% 30.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,711.0 Cr -0.8% 3.5% 14.7% Stock Analytics
DIVIS LABORATORIES ₹192,376.0 Cr -1% 7.3% 7.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,655.0 Cr -0.9% 10.1% 44.6% Stock Analytics
CIPLA ₹113,979.0 Cr -2.1% -1.8% -6% Stock Analytics
DR REDDYS LABORATORIES ₹96,204.7 Cr -5.8% -13.2% -7.7% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-5.6%

-0.3%

30.1%

SENSEX

-2.7%

-0.2%

-8%


You may also like the below Video Courses